Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 680

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease

Open access
Park, Seung-Jung, Kim, Young-Hak, Park, Duk-Woo, Yun, Sung-Cheol, Ahn, Jung-Min, Song, Hae Geun, Lee, Jong-Young, Kim, Won-Jang, Kang, Soo-Jin, Lee, Seung-Whan, Lee, Cheol Whan, Park, Seong-Wook, Chung, Cheol-Hyun, Lee, Jae-Won, Lim, Do-Sun, Rha, Seung-Woon, Lee, Sang-Gon, Gwon, Hyeon-Cheol, Kim, Hyo-Soo, Chae, In-Ho, Jang, Yangsoo, Jeong, Myung-Ho, Tahk, Seung-Jea, Seung, Ki Bae · 2011 · New England Journal of Medicine

Abstract

BACKGROUND: Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected left main coronary artery stenosis, although coronary-artery bypass grafting (CABG) has been considered to be the treatment of choice. METHODS: We randomly assigned patients with unprotected left main coronary artery stenosis to undergo CABG (300 patients) or PCI with sirolimus-eluting stents (300 patients). Using a wide margin for noninferiority, we compared the groups with respect to the primary composite end point of major adverse cardiac or cerebrovascular events (death from any cause, myocardial infarction, stroke, or ischemia-driven target-vessel revascularization) at 1 year. Event rates at 2 years were also compared between the two groups. RESULTS: The primary end point occurred in 26 patients assigned to PCI as compared with 20 patients assigned to CABG (cumulative event rate, 8.7% vs. 6.7%; absolute risk difference, 2.0 percentage points; 95% confidence interval [CI], -1.6 to 5.6; P=0.01 for noninferiority). By 2 years, the primary end point had occurred in 36 patients in the PCI group as compared with 24 in the CABG group (cumulative event rate, 12.2% vs. 8.1%; hazard ratio with PCI, 1.50; 95% CI, 0.90 to 2.52; P=0.12). The composite rate of death, myocardial infarction, or stroke at 2 years occurred in 13 and 14 patients in the two groups, respectively (cumulative event rate, 4.4% and 4.7%, respectively; hazard ratio, 0.92; 95% CI, 0.43 to 1.96; P=0.83). Ischemia-driven target-vessel revascularization occurred in 26 patients in the PCI group as compared with 12 patients in the CABG group (cumulative event rate, 9.0% vs. 4.2%; hazard ratio, 2.18; 95% CI, 1.10 to 4.32; P=0.02). CONCLUSIONS: In this randomized trial involving patients with unprotected left main coronary artery stenosis, PCI with sirolimus-eluting stents was shown to be noninferior to CABG with respect to major adverse cardiac or cerebrovascular events. However, the noninferiority margin was wide, and the results cannot be considered clinically directive. (Funded by the Cardiovascular Research Foundation, Seoul, Korea, and others; PRECOMBAT ClinicalTrials.gov number, NCT00422968.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1100452

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 680

Metadata

Authors
Park, S.-J., Kim, Y.-H., Park, D.-W., Yun, S.-C., Ahn, J.-M., Song, H. G., Lee, J.-Y., Kim, W.-J., Kang, S.-J., Lee, S.-W., Lee, C. W., Park, S.-W., Chung, C.-H., Lee, J.-W., Lim, D.-S., Rha, S.-W., Lee, S.-G., Gwon, H.-C., Kim, H.-S., Chae, I.-H., Jang, Y., Jeong, M.-H., Tahk, S.-J., & Seung, K. B.
Venue
New England Journal of Medicine
Published
2011-05-05
Volume
364
Issue
18
Pages
1718-1727
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2105095045
Cited by
680
References
28
FWCI
76.24
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. https://app.cochat.ai/papers/10.1056/nejmoa1100452
The paper
Park, S.-J., Kim, Y.-H., Park, D.-W., Yun, S.-C., Ahn, J.-M., Song, H. G., Lee, J.-Y., Kim, W.-J., Kang, S.-J., Lee, S.-W., Lee, C. W., Park, S.-W., Chung, C.-H., Lee, J.-W., Lim, D.-S., Rha, S.-W., Lee, S.-G., Gwon, H.-C., Kim, H.-S., . . . Seung, K. B. (2011). Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1100452

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.